Status:
TERMINATED
The MObile AssessMENT of Behavioral and Psychological Symptoms of Dementia in Amnestic MCI and AD (MOMENT) Study
Lead Sponsor:
Indiana University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer Disease
Mild Memory Disturbance
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
The purpose of this research study is to learn whether it is possible and useful for caregivers to report behavioral or psychological symptoms of people with mild memory problems or Alzheimer's diseas...
Detailed Description
As a part of this research study the patient and caregiver will undergo randomization, "like flipping a coin", to assign the patient and caregiver to one of two research study groups. The patient and ...
Eligibility Criteria
Inclusion
- The patient:
- Has Alzheimer's Disease (AD) or Amnestic Mild Cognitive Impairment (aMCI), is a Healthy Aging Brain Center, Eskenazi Health patient
- Community dwelling
- Has a legally authorized representative when they lack capacity to consent
- The caregiver:
- 18 or older
- No visual impairment
- Community dwelling
- Reports seeing patient most days of the week
Exclusion
- The patient:
- History of mental illness (Schizoaffective disorder, schizophrenia, bipolar)
- Participating in another study
- The potential participant with a diagnosis of either aMCI or AD communicates observable dissent.
- The caregiver:
- History of mental illness (Schizoaffective disorder, schizophrenia, bipolar)
- Participating in another study
Key Trial Info
Start Date :
October 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 4 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04482036
Start Date
October 23 2020
End Date
October 4 2021
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eskenazi Health
Indianapolis, Indiana, United States, 46202